1239 related articles for article (PubMed ID: 17624848)
1. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH
J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848
[TBL] [Abstract][Full Text] [Related]
2. Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes.
Trimnell A; Takagi A; Gupta M; Richie TL; Kappe SH; Wang R
J Immunol; 2009 Nov; 183(9):5870-8. PubMed ID: 19812194
[TBL] [Abstract][Full Text] [Related]
3. Genetically attenuated Plasmodium berghei liver stages persist and elicit sterile protection primarily via CD8 T cells.
Mueller AK; Deckert M; Heiss K; Goetz K; Matuschewski K; Schlüter D
Am J Pathol; 2007 Jul; 171(1):107-15. PubMed ID: 17591958
[TBL] [Abstract][Full Text] [Related]
4. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.
Mueller AK; Labaied M; Kappe SH; Matuschewski K
Nature; 2005 Jan; 433(7022):164-7. PubMed ID: 15580261
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of pre-erythrocytic whole organism vaccine strategies against the malaria parasite.
Friesen J; Matuschewski K
Vaccine; 2011 Sep; 29(40):7002-8. PubMed ID: 21787828
[TBL] [Abstract][Full Text] [Related]
6. Subpatent infection with nucleoside transporter 1-deficient Plasmodium blood stage parasites confers sterile protection against lethal malaria in mice.
Aly AS; Downie MJ; Mamoun CB; Kappe SH
Cell Microbiol; 2010 Jul; 12(7):930-8. PubMed ID: 20088947
[TBL] [Abstract][Full Text] [Related]
7. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.
Wang R; Charoenvit Y; Corradin G; De La Vega P; Franke ED; Hoffman SL
J Immunol; 1996 Nov; 157(9):4061-7. PubMed ID: 8892640
[TBL] [Abstract][Full Text] [Related]
8. Plasmodium yoelii sporozoites with simultaneous deletion of P52 and P36 are completely attenuated and confer sterile immunity against infection.
Labaied M; Harupa A; Dumpit RF; Coppens I; Mikolajczak SA; Kappe SH
Infect Immun; 2007 Aug; 75(8):3758-68. PubMed ID: 17517871
[TBL] [Abstract][Full Text] [Related]
9. IL-12p40-independent induction of protective immunity upon multiple Plasmodium berghei irradiated sporozoite immunizations.
Romero JF; Ibrahim GH; Renggli J; Himmelrich H; Graber P; Corradin G
Parasite Immunol; 2007 Nov; 29(11):541-8. PubMed ID: 17944743
[TBL] [Abstract][Full Text] [Related]
10. Genetically attenuated Plasmodium berghei liver stages induce sterile protracted protection that is mediated by major histocompatibility complex Class I-dependent interferon-gamma-producing CD8+ T cells.
Jobe O; Lumsden J; Mueller AK; Williams J; Silva-Rivera H; Kappe SH; Schwenk RJ; Matuschewski K; Krzych U
J Infect Dis; 2007 Aug; 196(4):599-607. PubMed ID: 17624847
[TBL] [Abstract][Full Text] [Related]
11. Efficient development of plasmodium liver stage-specific memory CD8+ T cells during the course of blood-stage malarial infection.
Hafalla JC; Rai U; Bernal-Rubio D; Rodriguez A; Zavala F
J Infect Dis; 2007 Dec; 196(12):1827-35. PubMed ID: 18190264
[TBL] [Abstract][Full Text] [Related]
12. IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model.
Doolan DL; Hoffman SL
J Immunol; 1999 Jul; 163(2):884-92. PubMed ID: 10395683
[TBL] [Abstract][Full Text] [Related]
13. A genetically attenuated parasite vaccine does not require liver stage persistence to elicit sterile protective immunity against sporozoite-induced malaria in mice.
Mikolajczak SA; Vaughan AM; Soliman JM; Kappe SH
J Infect Dis; 2010 Apr; 201(8):1270-1; author reply 1271-2. PubMed ID: 20225958
[No Abstract] [Full Text] [Related]
14. Genetically attenuated P36p-deficient Plasmodium berghei sporozoites confer long-lasting and partial cross-species protection.
Douradinha B; van Dijk MR; Ataide R; van Gemert GJ; Thompson J; Franetich JF; Mazier D; Luty AJ; Sauerwein R; Janse CJ; Waters AP; Mota MM
Int J Parasitol; 2007 Nov; 37(13):1511-9. PubMed ID: 17604034
[TBL] [Abstract][Full Text] [Related]
15. The Effects of radiation on the safety and protective efficacy of an attenuated Plasmodium yoelii sporozoite malaria vaccine.
Chattopadhyay R; Conteh S; Li M; James ER; Epstein JE; Hoffman SL
Vaccine; 2009 Jun; 27(27):3675-80. PubMed ID: 19071177
[TBL] [Abstract][Full Text] [Related]
16. Reduced Plasmodium berghei sporozoite liver load associates with low protective efficacy after intradermal immunization.
Nganou-Makamdop K; Ploemen I; Behet M; Van Gemert GJ; Hermsen C; Roestenberg M; Sauerwein RW
Parasite Immunol; 2012 Dec; 34(12):562-9. PubMed ID: 23171040
[TBL] [Abstract][Full Text] [Related]
17. Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites.
Butler NS; Schmidt NW; Vaughan AM; Aly AS; Kappe SH; Harty JT
Cell Host Microbe; 2011 Jun; 9(6):451-62. PubMed ID: 21669394
[TBL] [Abstract][Full Text] [Related]
18. Vaccination using radiation- or genetically attenuated live sporozoites.
Vaughan AM; Kappe SH
Methods Mol Biol; 2013; 923():549-66. PubMed ID: 22990804
[TBL] [Abstract][Full Text] [Related]
19. Priming of CD8+ T cell responses following immunization with heat-killed Plasmodium sporozoites.
Hafalla JC; Rai U; Morrot A; Bernal-Rubio D; Zavala F; Rodriguez A
Eur J Immunol; 2006 May; 36(5):1179-86. PubMed ID: 16598821
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity.
Silvie O; Rubinstein E; Franetich JF; Prenant M; Belnoue E; Rénia L; Hannoun L; Eling W; Levy S; Boucheix C; Mazier D
Nat Med; 2003 Jan; 9(1):93-6. PubMed ID: 12483205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
